DEST:OHLT

Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…

Jan 9 (Reuters) – The U.S. Federal Trade Commission won a ruling on Friday blocking Edwards Lifesciences’ (EW.N),…

Jan 9 (Reuters) – Schrodinger (SDGR.O), opens new tab said on Friday it is collaborating with Eli Lilly…

Item 1 of 3 U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. speaks during a…

WASHINGTON, Jan 6 (Reuters) – U.S. President Donald Trump said on Tuesday he would meet with representatives from…

Number of hikes rises from same time a year agoMedian list price increase is 4%, in line with…

Dec 26 (Reuters) – Social media platforms with infinite scrolling, auto-play and algorithmic feeds will be required to…

Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns